Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,228 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
BCL-B (BCL2L10) is overexpressed in patients suffering from multiple myeloma (MM) and drives an MM-like disease in transgenic mice.
Hamouda MA, Jacquel A, Robert G, Puissant A, Richez V, Cassel R, Fenouille N, Roulland S, Gilleron J, Griessinger E, Dubois A, Bailly-Maitre B, Goncalves D, Mallavialle A, Colosetti P, Marchetti S, Amiot M, Gomez-Bougie P, Rochet N, Deckert M, Avet-Loiseau H, Hofman P, Karsenti JM, Jeandel PY, Blin-Wakkach C, Nadel B, Cluzeau T, Anderson KC, Fuzibet JG, Auberger P, Luciano F. Hamouda MA, et al. Among authors: anderson kc. J Exp Med. 2016 Aug 22;213(9):1705-22. doi: 10.1084/jem.20150983. Epub 2016 Jul 25. J Exp Med. 2016. PMID: 27455953 Free PMC article.
Multiple myeloma.
Anderson KC, Shaughnessy JD Jr, Barlogie B, Harousseau JL, Roodman GD. Anderson KC, et al. Hematology Am Soc Hematol Educ Program. 2002:214-40. doi: 10.1182/asheducation-2002.1.214. Hematology Am Soc Hematol Educ Program. 2002. PMID: 12446425 Review.
Mcl-1 regulation and its role in multiple myeloma.
Le Gouill S, Podar K, Harousseau JL, Anderson KC. Le Gouill S, et al. Among authors: anderson kc. Cell Cycle. 2004 Oct;3(10):1259-62. doi: 10.4161/cc.3.10.1196. Epub 2004 Oct 3. Cell Cycle. 2004. PMID: 15467463 Review.
Recent advances in the treatment of Multiple Myeloma.
Yasui H, Hideshima T, Richardson PG, Anderson KC. Yasui H, et al. Among authors: anderson kc. Curr Pharm Biotechnol. 2006 Oct;7(5):381-93. doi: 10.2174/138920106778521569. Curr Pharm Biotechnol. 2006. PMID: 17076653 Review.
New frontiers in the treatment of multiple myeloma.
Hwang JJ, Ghobrial IM, Anderson KC. Hwang JJ, et al. Among authors: anderson kc. ScientificWorldJournal. 2006 Dec 6;6:1475-503. doi: 10.1100/tsw.2006.236. ScientificWorldJournal. 2006. PMID: 17160337 Free PMC article. Review.
The differentiation and stress response factor XBP-1 drives multiple myeloma pathogenesis.
Carrasco DR, Sukhdeo K, Protopopova M, Sinha R, Enos M, Carrasco DE, Zheng M, Mani M, Henderson J, Pinkus GS, Munshi N, Horner J, Ivanova EV, Protopopov A, Anderson KC, Tonon G, DePinho RA. Carrasco DR, et al. Among authors: anderson kc. Cancer Cell. 2007 Apr;11(4):349-60. doi: 10.1016/j.ccr.2007.02.015. Cancer Cell. 2007. PMID: 17418411 Free PMC article.
Targeting proteasomes as therapy in multiple myeloma.
Chauhan D, Hideshima T, Anderson KC. Chauhan D, et al. Among authors: anderson kc. Adv Exp Med Biol. 2008;615:251-60. doi: 10.1007/978-1-4020-6554-5_12. Adv Exp Med Biol. 2008. PMID: 18437898 Review.
1,228 results